Loading clinical trials...
Loading clinical trials...
The aim of the study is to evaluate in clinical practice the efficacy and safety of ombitasvir/paritaprevir/ ritonavir and dasabuvir administered for 8 weeks in treatment-naïve participants with genot...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Hepa C
NCT02578693 · Chronic Hepatitis C Infection
NCT02143401 · Cirrhosis, Hepatitis B Infection, and more
NCT01866930 · Chronic Hepatitis C Infection
NCT02190305 · HIV Infections, Hepatitis B Infections, and more
NCT05601518 · Hepatitis C Infection
Carrion, Jose Antonio, PhD
Barcelona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions